- Zacks
McKesson (MCK) Hits 52-Week High: What's Driving the Stock?
Investors are optimistic about McKesson's (MCK) strength in its Biologics business.
- Zacks
Here's Why McKesson (MCK) is a Strong Momentum Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
- Zacks
McKesson (MCK) Q4 Earnings Miss Estimates, Revenues Up Y/Y
McKesson's (MCK) fourth-quarter fiscal 2024 results showcase growth in the U.S. Pharmaceutical while lower COVID-related sales hurt the Medical Surgical Solutions segment.
